Home > Author

Blog Posts by Author: Patricia Goede

How to Increase Clinical Trial Participation in Community Oncology

In November, I co-authored an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists, Johnny Walker, Director of Research of Utah Cancer Specialists, and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “Increasing Clinical Trial Participation in the Community,” explores the structural barriers to...

Read


Using Real-World Data for Oncology Treatment

Last year, I had the pleasure of co-authoring an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists, Nitin Chandramouli, MD, FACP, President of Utah Cancer Specialists, and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “Treatment Patterns and Prescribing Practices Based on Real-World Data”...

Read


Integrating Informatics for Clinical-Genomic Collaboration and Analysis

I recently had the pleasure of co-authoring an article in Oncology Practice Management. The article, titled “An Integrated Informatics Approach for Clinical-Genomic Knowledge Sharing and Analysis” outlines the design of a real-time registry that aggregates heterogeneous clinical and genomic data (along with other molecular results) in a unified structure to identify, vet, and fulfill...

Read


How Precision Medicine and Data Analytics Impact the Journey of Patients with Cancer

Earlier this year, I had the pleasure of co-authoring an article in Oncology Practice Management with Randy Erickson, RN, MBA, Chief Executive Officer of Utah Cancer Specialists and Linh Mekuria, MPA, clinical informaticist with XIFIN, Inc. The article, titled “The Intersection of Precision Medicine and Data Analysis in the Community Oncology Setting” explores the role of precision medicine and...

Read


U.S. National Institutes of Health (NIH) Announces the Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19: Here’s What Laboratories Need to Know to Participate

The National Institutes of Health (NIH) announced a new initiative aimed to accelerate innovative development and commercialization of COVID-19 testing technologies to speed delivery of accurate, easy to use, scalable tests to all Americans.1 The $1.5 billion investment of Federal stimulus funding introduced the Rapid Acceleration of Diagnostics (RADx) Initiative to provide funding for the rapid...

Read


Is Your Lab Developing COVID Related Tests? Receive Federal Funding Resources

In response to the COVID-19 global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), has expanded funding opportunities up to $749K to establish public-private partnerships with diagnostic providers for the purpose of developing solutions to mitigate the public health impact of the...

Read